Header Logo

Connection

Joan Merrill to Pyrazoles

Back to Details
This is a "connection" page, showing publications Joan Merrill has written about Pyrazoles.
Joan Merrill
Connection Strength
0.159
Pyrazoles
  1. A double-blind, randomized, placebo-controlled, phase II trial of baricitinib for systemic lupus erythematosus: how to optimize lupus trials to examine effects on cutaneous lupus erythematosus. Br J Dermatol. 2019 05; 180(5):964-965.
    View in: PubMed
    Score: 0.159
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.